First Time Loading...
A

Alvotech SA
NASDAQ:ALVO

Watchlist Manager
Alvotech SA
NASDAQ:ALVO
Watchlist
Price: 13.335 USD 0.34% Market Closed
Updated: May 14, 2024

Intrinsic Value

Alvotech SA is a LU-based company operating in Biotechnology industry. [ Read More ]

The intrinsic value of one ALVO stock under the Base Case scenario is 19.412 USD. Compared to the current market price of 13.335 USD, Alvotech SA is Undervalued by 31%.

Key Points:
ALVO Intrinsic Value
Base Case
19.412 USD
Undervaluation 31%
Intrinsic Value
Price
A
Base Case Scenario

Valuation Backtest
Alvotech SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ALVO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Alvotech SA

Provide an overview of the primary business activities
of Alvotech SA.

What unique competitive advantages
does Alvotech SA hold over its rivals?

What risks and challenges
does Alvotech SA face in the near future?

Summarize the latest earnings call
of Alvotech SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Alvotech SA.

Provide P/S
for Alvotech SA.

Provide P/E
for Alvotech SA.

Provide P/OCF
for Alvotech SA.

Provide P/FCFE
for Alvotech SA.

Provide P/B
for Alvotech SA.

Provide EV/S
for Alvotech SA.

Provide EV/GP
for Alvotech SA.

Provide EV/EBITDA
for Alvotech SA.

Provide EV/EBIT
for Alvotech SA.

Provide EV/OCF
for Alvotech SA.

Provide EV/FCFF
for Alvotech SA.

Provide EV/IC
for Alvotech SA.

Show me price targets
for Alvotech SA made by professional analysts.

What are the Revenue projections
for Alvotech SA?

How accurate were the past Revenue estimates
for Alvotech SA?

What are the Net Income projections
for Alvotech SA?

How accurate were the past Net Income estimates
for Alvotech SA?

What are the EPS projections
for Alvotech SA?

How accurate were the past EPS estimates
for Alvotech SA?

What are the EBIT projections
for Alvotech SA?

How accurate were the past EBIT estimates
for Alvotech SA?

Compare the revenue forecasts
for Alvotech SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Alvotech SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Alvotech SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Alvotech SA compared to its peers.

Compare the P/E ratios
of Alvotech SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Alvotech SA with its peers.

Analyze the financial leverage
of Alvotech SA compared to its main competitors.

Show all profitability ratios
for Alvotech SA.

Provide ROE
for Alvotech SA.

Provide ROA
for Alvotech SA.

Provide ROIC
for Alvotech SA.

Provide ROCE
for Alvotech SA.

Provide Gross Margin
for Alvotech SA.

Provide Operating Margin
for Alvotech SA.

Provide Net Margin
for Alvotech SA.

Provide FCF Margin
for Alvotech SA.

Show all solvency ratios
for Alvotech SA.

Provide D/E Ratio
for Alvotech SA.

Provide D/A Ratio
for Alvotech SA.

Provide Interest Coverage Ratio
for Alvotech SA.

Provide Altman Z-Score Ratio
for Alvotech SA.

Provide Quick Ratio
for Alvotech SA.

Provide Current Ratio
for Alvotech SA.

Provide Cash Ratio
for Alvotech SA.

What is the historical Revenue growth
over the last 5 years for Alvotech SA?

What is the historical Net Income growth
over the last 5 years for Alvotech SA?

What is the current Free Cash Flow
of Alvotech SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Alvotech SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alvotech SA

Current Assets 194.8m
Cash & Short-Term Investments 11.2m
Receivables 87.2m
Other Current Assets 96.5m
Non-Current Assets 755.2m
Long-Term Investments 18.5m
PP&E 356.6m
Intangibles 31.1m
Other Non-Current Assets 349m
Current Liabilities 261m
Accounts Payable 80.6m
Accrued Liabilities 62.7m
Other Current Liabilities 117.7m
Non-Current Liabilities 1.6B
Long-Term Debt 1B
Other Non-Current Liabilities 593.9m
Efficiency

Earnings Waterfall
Alvotech SA

Revenue
93.4m USD
Cost of Revenue
-160.9m USD
Gross Profit
-67.5m USD
Operating Expenses
-287.4m USD
Operating Income
-354.9m USD
Other Expenses
-196.9m USD
Net Income
-551.7m USD

Free Cash Flow Analysis
Alvotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ALVO Profitability Score
Profitability Due Diligence

Alvotech SA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
Positive 1-Year Revenue Growth
40/100
Profitability
Score

Alvotech SA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

ALVO Solvency Score
Solvency Due Diligence

Alvotech SA's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
23/100
Solvency
Score

Alvotech SA's solvency score is 23/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALVO Price Targets Summary
Alvotech SA

Wall Street analysts forecast ALVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALVO is 16.83 USD with a low forecast of 6.06 USD and a high forecast of 29.4 USD.

Lowest
Price Target
6.06 USD
55% Downside
Average
Price Target
16.83 USD
26% Upside
Highest
Price Target
29.4 USD
120% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ALVO Price
Alvotech SA

1M 1M
+7%
6M 6M
+48%
1Y 1Y
+38%
3Y 3Y
+40%
5Y 5Y
+40%
10Y 10Y
+40%
Annual Price Range
13.335
52w Low
6.9
52w High
17.27
Price Metrics
Average Annual Return 5.04%
Standard Deviation of Annual Returns
N/A
Max Drawdown -51%
Shares Statistics
Market Capitalization 3.6B USD
Shares Outstanding 279 567 008
Percentage of Shares Shorted 0.27%

ALVO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Alvotech SA

Country

Luxembourg

Industry

Biotechnology

Market Cap

3.6B USD

Dividend Yield

0%

Description

Alvotech SA is a LU-based company operating in Biotechnology industry. Alvotech SA is a biotechnology company. The firm is focused on the development and manufacture of biosimilar medicines for patients globally. The company is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). The company has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Contact

Luxembourg
9, Rue De Bitbourg
+35244224500

IPO

2020-11-09

Employees

805

Officers

COO & Director
Mr. Faysal Kalmoua
CEO, Founder & Executive Chairman
Mr. Robert Wessman
Chief Financial Officer
Mr. Joel Morales
Chief Technical Officer
Mr. Giedrius Zunda
Chief Scientific Officer
Mr. Joseph E. McClellan
General Counsel
Ms. Tanya Zharov
Show More
Chief Commercial Officer
Mr. Anil Okay
Chief Strategy Officer
Mr. Ming Li
Chief Quality Officer
Ms. Christina Siniscalchi
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALVO stock?

The intrinsic value of one ALVO stock under the Base Case scenario is 19.412 USD.

Is ALVO stock undervalued or overvalued?

Compared to the current market price of 13.335 USD, Alvotech SA is Undervalued by 31%.